| Literature DB >> 27226776 |
Moon-Soo Kim1, Jeong-Won Yun1, Jin-Ho Park1, Bong-Wook Park1, Young-Hoon Kang1, Young-Sool Hah2, Sun-Chul Hwang3, Dong Kyun Woo4, June-Ho Byun1.
Abstract
The deleterious role of cigarette smoke has long been documented in various human diseases including periodontal complications. In this report, we examined this adverse effect of cigarette smoke on human gingival fibroblasts (HGFs) which are critical not only in maintaining gingival tissue architecture but also in mediating immune responses. As well documented in other cell types, we also observed that cigarette smoke promoted cellular reactive oxygen species in HGFs. And we found that this cigarette smoke-induced oxidative stress reduced HGF viability through inducing apoptosis. Our results indicated that an increased Bax/Bcl-xL ratio and resulting caspase activation underlie the apoptotic death in HGFs exposed to cigarette smoke. Furthermore, we detected that cigarette smoke also triggered autophagy, an integrated cellular stress response. Interesting, a pharmacological suppression of the cigarette smoke-induced autophagy led to a further reduction in HGF viability while a pharmacological promotion of autophagy increased the viability of HGFs with cigarette smoke exposures. These findings suggest a protective role for autophagy in HGFs stressed with cigarette smoke, highlighting that modulation of autophagy can be a novel therapeutic target in periodontal complications with cigarette smoke.Entities:
Keywords: apoptosis; autophagy; cigarette smoke; gingival fibroblast; oxidative stress
Mesh:
Substances:
Year: 2016 PMID: 27226776 PMCID: PMC4879768 DOI: 10.7150/ijms.14592
Source DB: PubMed Journal: Int J Med Sci ISSN: 1449-1907 Impact factor: 3.738
Figure 1Cigarette smoke extract (CSE) promotes cellular ROS production and reduces viability of human gingival fibroblasts (HGFs). A: Flow cytometry analysis for cellular H2O2 levels by DCF-DA staining after CSE treatments on HGFs for 24 hr. B: HGF viability followed by 24 hr and 48 hr treatments. C: HGF viability followed by 24hr CSE treatments in combination with NAC as indicated. Data are expressed as the mean ± SD, * indicates P < 0.05, ** indicates P < 0.01 and *** indicates P < 0.001.
Figure 2CSE exposures induce apoptotic death in HGFs. A: Flow cytometry analysis for discrimination of HGFs using double staining with propidium iodide and FITC-labeled annexin-V after CSE treatments for 24 hr. Percentage of double positive cells (apoptotic death) were indicated in red. B: Western blot analysis for pro-apoptotic Bax and anti-apoptotic Bcl-xL protein expression levels in HGFs followed by 24hr CSE treatments. Quantitation of Bax and Bcl-xL protein levels normalized to no CSE treatment sample (0% CSE) was shown under each band. Actin was probed as a loading control. C: Caspase 3/7 activity assay for apoptosis in HGFs with 24 hr and 48 hr CSE treatments. Data are expressed as the mean ± SD, ** indicates P < 0.01 and *** indicates P < 0.001.
Figure 3CSE exposures cause autophagy in HGFs. A: Western blot analysis for LC3II (an autophagy marker) protein expression levels in HGFs followed by 24hr CSE treatments. Quantitation of LC3II protein levels normalized to no CSE treatment sample (0% CSE) was shown under each band. Actin was probed as a loading control. B: Immunocytochemistry analysis for LC3II fluorescent puncta (cytosolic autophagosomes) in HGFs treated with CSE. Arrows indicate cytosolic LC3II puncta. Quantitation of LC3 puncta per cell was presented in the bottom margin.
Figure 4Autophage attenuates reduction in HGF viability in response to CSE. A: HGF viability followed by 24hr CSE treatments in combination with 3-methyladenine (3-MA, an autophagy inhibitor) as indicated. B: HGF viability followed by 24hr CSE treatments in combination with rapamycin (Rap, an autophagy inducer) as indicated. Data are expressed as the mean ± SD, * indicates P < 0.05, ** indicates P < 0.01 and *** indicates P < 0.001.